Organogenesis Holdings (ORGO) EBITDA Margin Growth (5y) (2022 - 2026)
Organogenesis Holdings (ORGO) EBITDA Margin Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Organogenesis Holdings | 240.62 Mn | 193.78 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13,569.00 |
| Mar 31, 2026 | -19,735.00 |
| Dec 31, 2025 | 784.00 |
| Sep 30, 2025 | -888.00 |
| Jun 30, 2025 | -919.00 |
| Mar 31, 2025 | -642.00 |
| Dec 31, 2024 | 900.00 |
| Sep 30, 2024 | 916.00 |
| Jun 30, 2024 | -724.00 |
| Mar 31, 2024 | 256.00 |
| Dec 31, 2023 | 577.00 |
| Sep 30, 2023 | 2,725.00 |
| Jun 30, 2023 | 4,740.00 |
| Mar 31, 2023 | 5,252.00 |
| Dec 31, 2022 | 1,207.00 |
| Sep 30, 2022 | 661.00 |
| Jun 30, 2022 | 522.00 |
| Mar 31, 2022 | 733.00 |